CCHT(SZ:000661) Zhi Tong Cai Jing·2025-11-14 12:12Core Viewpoint - Changchun High-tech (000661.SZ) is required by the China Securities Regulatory Commission (CSRC) to provide additional explanations regarding the use of raised funds and specific details about its AI large model business as part of its application for listing on the Hong Kong Stock Exchange [1] Group 1: Regulatory Requirements - The CSRC has requested Changchun High-tech to clarify the penetration situation of its controlling shareholder, Jilin Province Xinzhen Fund Partnership, and whether there are any legal restrictions on shareholding [2] - The company must explain the potential impact of its controlling shareholder's equity pledge on the control of the issuer before and after the listing [2] - The CSRC requires a detailed explanation of the company's business related to AI large models, including application scenarios and specific functions [3] Group 2: Fundraising and Business Operations - Changchun High-tech is asked to provide a detailed account of the intended use of the funds raised from the listing [4] - The company must confirm the legality and compliance of its establishment and previous equity changes, focusing on significant aspects [5] - The company operates in various fields, including therapeutic biopharmaceuticals, chemical drugs, vaccines, and traditional Chinese medicine, and is one of the few domestic pharmaceutical companies with full industry chain capabilities in these drug types [5]